SCHEMBL4746162

SCHEMBL4746162

Cc1ccc2[nH]c(=O)c(CNCCCO)cc2c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.70
ALDH1A1 P00352 9/20 0.70
MAPT P10636 4/20 0.70
HPGD P15428 2/20 0.70
TDP1 Q9NUW8 1/20 0.70
HSD17B10 Q99714 5/20 0.61
GAA P10253 2/20 0.61
ALOX15 P16050 1/20 0.61
CASP1 P29466 1/20 0.61
CASP7 P55210 1/20 0.61
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
TAAR1 Q96RJ0 2/20 0.53
DAO P14920 1/20 0.50
HTT P42858 1/20 0.50
POLB P06746 2/20 0.49
HIF1A Q16665 2/20 0.48
NPC1 O15118 1/20 0.48
LMNA P02545 1/20 0.48
PKM P14618 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4745002 0.85 ALDH1A1 (0.67) KDM4EALDH1A1MAPTHPGDTDP1
SCHEMBL4114418 0.78 KDM4E (0.71) KDM4EALDH1A1MAPTHPGDTDP1
SCHEMBL22184914 0.76 KDM4E (0.72) KDM4EALDH1A1MAPTHPGDTDP1
SCHEMBL4746075 0.74 KDM4E (0.65) KDM4EALDH1A1MAPTHPGDTDP1
SCHEMBL27764047 0.73 KDM4E (0.64) KDM4EALDH1A1MAPTHPGDTDP1
SCHEMBL20800911 0.71 TAAR1 (0.65) KDM4EALDH1A1MAPTHPGDTDP1
SCHEMBL4075930 0.71 POLB (0.85) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL4075932 0.68 POLB (0.79) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL16767844 0.68 DAO (1.00) KDM4EALDH1A1MAPTHPGDTDP1
SCHEMBL30705488 0.68 KDM4E (0.57) KDM4EALDH1A1MAPTHPGDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008113006-A1 METHODS OF USING QUINOLINONE COMPOUNDS IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-09-18 WO disclosed
WO-2008113006-A1 METHODS OF USING QUINOLINONE COMPOUNDS IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-09-18 WO disclosed